Neochem Bio Solutions Limited (NSE:NEOCHEM)
India · Delayed Price · Currency is INR 98.45
+4.45 (4.73%)
At close: Jun 17, 2026
Neochem Bio Solutions Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,107 | 841.73 | 611.46 | 481.88 | 494.98 |
Other Revenue | - | -0 | 1.14 | - | 0.74 |
| 1,107 | 841.73 | 612.6 | 481.88 | 495.72 | |
Revenue Growth (YoY) | 31.51% | 37.40% | 27.13% | -2.79% | - |
Cost of Revenue | 763.63 | 570.41 | 394.37 | 328.82 | - |
Gross Profit | 343.36 | 271.32 | 218.24 | 153.07 | 495.72 |
Selling, General & Admin | 81.66 | 95.08 | 83.44 | 78.52 | 472.23 |
Other Operating Expenses | 36.2 | 27.54 | 65.39 | 26.96 | -0 |
Operating Expenses | 130.29 | 135.89 | 161.02 | 117.65 | 483.12 |
Operating Income | 213.07 | 135.43 | 57.21 | 35.42 | 12.6 |
Interest Expense | -35.05 | -31.22 | -25.12 | -19.51 | - |
Interest & Investment Income | - | 0.13 | 0.04 | 0.06 | 0.19 |
Currency Exchange Gain (Loss) | - | - | 0.15 | - | - |
Other Non Operating Income (Expenses) | - | -2.47 | -4.48 | -0.78 | 0 |
EBT Excluding Unusual Items | 178.01 | 101.87 | 27.8 | 15.18 | 12.79 |
Gain (Loss) on Sale of Assets | - | 0.74 | 0.18 | - | - |
Other Unusual Items | -6.19 | - | - | - | - |
Pretax Income | 171.83 | 102.61 | 27.98 | 15.18 | 12.79 |
Income Tax Expense | 51.56 | 25.11 | 8.71 | 4.46 | 3.12 |
Net Income | 120.27 | 77.51 | 19.27 | 10.73 | 9.67 |
Net Income to Common | 120.27 | 77.51 | 19.27 | 10.73 | 9.67 |
Net Income Growth | 55.17% | 302.21% | 79.61% | 10.91% | - |
Shares Outstanding (Basic) | 14 | 12 | 7 | 5 | - |
Shares Outstanding (Diluted) | 14 | 12 | 7 | 5 | - |
Shares Change (YoY) | 18.20% | 75.00% | 26.16% | - | - |
EPS (Basic) | 8.71 | 6.64 | 2.89 | 2.03 | - |
EPS (Diluted) | 8.71 | 6.64 | 2.89 | 2.03 | - |
EPS Growth | 31.27% | 129.83% | 42.36% | - | - |
Free Cash Flow | -216.08 | 14.54 | -90.16 | -40.72 | - |
Free Cash Flow Per Share | -15.65 | 1.24 | -13.51 | -7.70 | - |
Gross Margin | 31.02% | 32.23% | 35.63% | 31.76% | 100.00% |
Operating Margin | 19.25% | 16.09% | 9.34% | 7.35% | 2.54% |
Profit Margin | 10.86% | 9.21% | 3.15% | 2.23% | 1.95% |
Free Cash Flow Margin | -19.52% | 1.73% | -14.72% | -8.45% | - |
EBITDA | 225.51 | 148.71 | 69.41 | 47.59 | 23.49 |
EBITDA Margin | 20.37% | 17.67% | 11.33% | 9.88% | 4.74% |
D&A For EBITDA | 12.44 | 13.28 | 12.2 | 12.17 | 10.89 |
EBIT | 213.07 | 135.43 | 57.21 | 35.42 | 12.6 |
EBIT Margin | 19.25% | 16.09% | 9.34% | 7.35% | 2.54% |
Effective Tax Rate | 30.01% | 24.47% | 31.13% | 29.34% | 24.39% |
Revenue as Reported | 1,134 | 861.54 | 620.08 | 487.9 | 495.91 |
Advertising Expenses | - | 8.27 | - | 10.38 | - |